Sony is forming a new company to focus on genome research with a view towards realizing personalized medicine and healthcare. The venture, currently called P5 Inc, is a collaboration with M3, a medical company in which Sony is the majority stakeholder, and Illumina, a US-based manufacturer of genome-sequencing equipment. News of the tie-up between Sony and Illumina, which will be a minority investor, was first reported by Jiji Press last year.
Does this represent actual consumer entry by Sony or just some sort of weird plaything? Is it disruptive as the WalkMan was or will it wither away?
It’ll be fun to find out.